BlackRock
CRVO icon

BlackRock’s CervoMed CRVO Stock Holding History

BlackRock’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
53,845
+2,185
+4% +$7.7K ﹤0.01% 4875
2026
Q1 		$204K Buy
51,660
+2,526
+5% +$13.2K ﹤0.01% 4765
2025
Q4 		$388K Buy
49,134
+302
+0.6% +$2.43K ﹤0.01% 4548
2025
Q3 		$395K Sell
48,832
-55,217
-53% -$474K ﹤0.01% 4522
2025
Q2 		$654K Sell
104,049
-244,574
-70% -$2.08M ﹤0.01% 4384
2025
Q1 		$3.19M Buy
348,623
+24,315
+7% +$92.6K ﹤0.01% 3828
2024
Q4 		$759K Buy
324,308
+5,542
+2% +$53.9K ﹤0.01% 4300
2024
Q3 		$4.65M Buy
318,766
+14,831
+5% +$230K ﹤0.01% 3727
2024
Q2 		$5.2M Buy
303,935
+282,119
+1,293% +$6.17M ﹤0.01% 3669
2024
Q1 		$508K Sell
21,816
-84
-0.4% -$1.12K ﹤0.01% 4370
2023
Q4 		$167K Hold
21,900
– – ﹤0.01% 4684
2023
Q3 		$101K Sell
21,900
-1
-0% -$5 ﹤0.01% 4845
2023
Q2 		$110K Hold
21,901
– – ﹤0.01% 4882
2023
Q1 		$136K Hold
21,901
– – ﹤0.01% 4891
2022
Q4 		$166K Hold
21,901
– – ﹤0.01% 4901
2022
Q3 		$176K Hold
21,901
– – ﹤0.01% 5006
2022
Q2 		$219K Sell
21,901
-2
-0% -$25 ﹤0.01% 5006
2022
Q1 		$411K Hold
21,903
– – ﹤0.01% 4927
2021
Q4 		$501K Buy
21,903
+85
+0.4% +$2.66K ﹤0.01% 4871
2021
Q3 		$834K Hold
21,818
– – ﹤0.01% 4606
2021
Q2 		$1.2M Sell
21,818
-5,441
-20% -$301K ﹤0.01% 4458
2021
Q1 		$1.88M Buy
27,259
+16,186
+146% +$1.36M ﹤0.01% 4303
2020
Q4 		$660K Hold
11,073
– – ﹤0.01% 4301
2020
Q3 		$699K Hold
11,073
– – ﹤0.01% 4198
2020
Q2 		$810K Buy
11,073
+129
+1% +$7.85K ﹤0.01% 4096
2020
Q1 		$260K Hold
10,944
– – ﹤0.01% 4183
2019
Q4 		$378K Buy
+10,944
New +$669K ﹤0.01% 4207
2018
Q2 		– Sell
-14
Closed -$9K – 5020
2018
Q1 		$9K Hold
14
– – ﹤0.01% 4664
2017
Q4 		$19K Hold
14
– – ﹤0.01% 4574
2017
Q3 		$26K Hold
14
– – ﹤0.01% 4562
2017
Q2 		$38K Buy
+14
New +$45.1K ﹤0.01% 4563

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

BlackRock's CRVO Position: Q2 2026 in Review

BlackRock increased its CervoMed (CRVO) stake by 4.2% in Q2 2026, buying an estimated $7.7K and bringing the position to 53,845 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #4875.

BlackRock first reported a position in CRVO in Q2 2017 and has held it in 31 quarters since. The position peaked at $5.2M in Q2 2024. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • BlackRock held 53,845 shares of CervoMed worth $167K as of Q2 2026.
  • BlackRock bought 2,185 CervoMed shares in Q2 2026, an estimated $7.7K.
  • CervoMed made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4875 holding.
  • BlackRock first reported a position in CervoMed in Q2 2017 and has held it in 31 quarters since.
  • BlackRock's CervoMed position peaked at $5.2M in Q2 2024.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.